Drug Shortage Report for LUPIN-CEPHALEXIN

Last updated on 2023-09-13 History
Report ID 193303
Drug Identification Number 02469189
Brand name LUPIN-CEPHALEXIN
Common or Proper name LUPIN-CEPHALEXIN
Company Name LUPIN PHARMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size BO 150mL; BO 100mL
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-05-29
Estimated end date
Actual end date 2023-09-12
Shortage status Resolved
Updated date 2023-09-13
Company comments BO 100mL shortage since July 21, 2023; Estimated end Sept 15, 2023
Health Canada comments
Tier 3 Status No
Contact Address 550-1111 RUE ST-CHARLES OUEST
LONGUEUIL, QUEBEC
CANADA J4K 5G4
Company contact information lupin@lsu3pl.ca (Customer service / Service à la clientèle)

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-09-13 French Compare
v10 2023-09-13 English Compare
v9 2023-09-04 French Compare
v8 2023-09-04 English Compare
v7 2023-07-21 French Compare
v6 2023-07-21 English Compare
v5 2023-05-30 English Compare
v4 2023-05-29 French Compare
v3 2023-05-29 English Compare
v2 2023-05-29 English Compare
v1 2023-05-29 English Compare

Showing 1 to 11 of 11